The HiFi Health News Podcast
The HiFi Health News Podcast
Podcast Description
The American healthcare landscape often confounds and confuses patients as they try to navigate their care and financial responsibilities. The system is in need of change, but sweeping improvement isn’t coming tomorrow. The HiFi Health News Podcast aims to help patients become more informed consumers of healthcare.
Podcast Insights
Content Themes
The podcast explores key themes in healthcare consumer education, including navigating long-term care challenges, the financial implications of medical treatment, and the intersection of public health and violence. Recent episodes include discussions on finding memory care, handling unexpected medical bills, and understanding the financial aspects of cancer treatment.
The American healthcare landscape often confounds and confuses patients as they try to navigate their care and financial responsibilities. The system is in need of change, but sweeping improvement isn’t coming tomorrow. The HiFi Health News Podcast aims to help patients become more informed consumers of healthcare.
GLP-1s such as semaglutide and tirzepatide, originally formulated
to treat patients with diabetes, have been touted as a solution for weight
loss. However, these drugs come with some serious side effects – and high price
tags – that make 65% of patients taking them for weight loss discontinue them
within a year. In this episode, researcher and patient advocate Ragen Chastain
discusses what to know before taking a GLP-1 for weight loss.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.